Authors: Cauvin, C Le Bourdonnec, B Norberg, B Henichart, JP Durant, F

Citation: C. Cauvin et al., Pyrazolidine-3,5-dione angiotensin-II receptor antagonists, ACT CRYST C, 57, 2001, pp. 1330-1332

Authors: Le Bourdonnec, B El Kouhen, R Poda, G Law, PY Loh, HH Ferguson, DM Portoghese, PS

Citation: B. Le Bourdonnec et al., Covalently induced activation of the delta opioid receptor by a fluorogenic affinity label, 7 '-(phthalaldehyde-carboxamido)naltrindole (PNTI), J MED CHEM, 44(7), 2001, pp. 1017-1020

Authors: Le Bourdonnec, B Meulon, E Yous, S Goossens, JF Houssin, R Henichart, JP

Citation: B. Le Bourdonnec et al., Synthesis and pharmacological evaluation of new pyrazolidine-3,5-diones asAT(1) angiotensin II receptor antagonists, J MED CHEM, 43(14), 2000, pp. 2685-2697

Authors: Le Bourdonnec, B El Kouhen, R Lunzer, MM Law, PY Loh, HH Portoghese, PS

Citation: B. Le Bourdonnec et al., Reporter affinity labels: An o-phthalaldehyde derivative of beta-naltrexamine as a fluorogenic ligand for opioid receptors, J MED CHEM, 43(13), 2000, pp. 2489-2492

Authors: Le Bourdonnec, B Meulon, E Yous, S Houssin, R Henichart, JP

Citation: B. Le Bourdonnec et al., A new synthesis of N-alkyl pyrazolidine-3,5-diones and tetrahydropyridazine-3,6-diones, J HETERO CH, 37(5), 2000, pp. 1209-1212